EDP Biotech Corporation News
Follow our progress, be the first to know when ColoPlex™ with marker is available.
ACS Caner Action Network Tennessee Policy Forum: Precision Medicine and Biomarkers
ACS Cancer Action Network Tennessee Policy Forum: Precision Medicine and Biomarkers EDP Biotech participated in the September 23rd American Cancer Society - Cancer Action Network Tennessee Policy Forum focused on work being done in the field of Precision Medicine and...
Innov865 2020 Impact Awards Teaser
EDP Biotech (who presented our ColoPlex colorectal cancer blood test in 2019) is highlighted this year for our impact in the local community related to our COVID antibody testing response!
Living East Tennessee: Local company providing Covid-19 testing for families, businesses and schools
by: Justin Young Posted: Aug 31, 2020 / 10:30 AM EDT / Updated: Aug 31, 2020 / 02:41 PM EDT KNOXVILLE, Tenn. (WATE) – A local company, EDP Biotech Corporation, has made it its mission to develop cost-effective tests to detect diseases such as cancer early. During the...
Knoxville’s Eric Mayer discusses EDP Biotech’s antibody testing during “36|86 Entrepreneurship Festival”
“EDP stands for early detection products,” Mayer explained in a discussion with LST Executive Director Abby Trotter. With that mantra, it was only natural that the pandemic caused the company to ask, “How can we respond and bring our expertise to the need for...
A Day in the Life Sciences LIVE: COVID Testing for Your Business with EDP Biotech
As businesses seek to return to offices and keep employees and customers safe, testing continues to be an incredibly important piece of the puzzle. But what are the options? Join us and Eric Mayer of EDP Biotech as we discuss the latest in testing technology, how to...
Knoxville lab helps businesses with COVID-19 reopening plans
Published: Jul. 22, 2020 at 11:35 PM EDT|Updated: 11 hours ago KNOXVILLE, Tenn. (WVLT) - COVID-19 cases continue to rise, which puts the pressure on business managers developing reopening plans. A Knoxville lab, which normally researches early cancer...
EDP Biotech now able to be an antibody testing resource for local employers
EDP Biotech is able to be a testing resource for local employers, thanks to the local company’s designation as a CLIA-certified lab. CLIA stands for the Clinical Laboratory Improvement Amendments of 1988 that established federal regulatory standards applicable to all...
EDP Biotech joins second cohort of Chattanooga’s “HealthTech Accelerator”
Eight companies, including two from Knoxville whose progress has been chronicled in past articles on teknovation.biz, will comprise the second cohort of Chattanooga’s “HealthTech Accelerator.” The two Knoxville-based participants are Qardian Labs, the artificial...
COVID-19 Antibody Testing In Tennessee
EDP Biotech Corporation is a local small business whose mission is to develop and commercialize cost-effective blood tests to detect disease early. We operate a CLIA Certified laboratory (CLIA 44D2184836) and an ISO Certified Bio-Safety Level II facility right here...
Two Knoxville companies named winners in yesterday’s “Pitch for Good: Pandemic Edition” event
EDP Biotech captured first place and $2,000 in the “Idea in Motion” category for its recently launched COVID-19 antibody testing service and upcoming product. As Eric Mayer, the company’s CEO, told attendees at last week’s Knoxville Technology Council forum, EDP...
Knoxville firm EDP Biotech is working overtime to develop a COVID-19 antibody test
Knoxville News Sentinel - A small Knoxville firm that manufactures early detection tests for colon cancer has switched gears to quickly develop a COVID-19 antibody test. EDP Biotech CEO Eric Mayer told Knox News the company is pursuing certifications to sell and...
EDP Biotech FDA Notification and Listing for COVID-19 Serology (antibody) Testing
EDP Biotech has recently notified the US FDA, and received a listing on the FDA.gov FAQ website, related to its plans to perform COVID-19 serology (antibody) testing in the state of Tennessee. EDP Biotech’s mission has always been to develop and commercialize cost...